Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. Announces Rêveur Corporation Revenue Increases in October Over Previous Month
DGAP-News: Lifestyle Delivery Systems Inc. / Key word(s): Monthly Figures/Development of Sales Lifestyle Delivery Systems Inc. Announces Rêveur Corporation Revenue Increases in October Over Previous Month Rêveur Corporation continues to increase its revenue month over month, and the Company expects this trend to continue for the month of November 2018. LDS’ CEO, Brad Eckenweiler, stated, “These revenue numbers are very encouraging and are possibly the best representation of the future outlook for the Adelanto facility.” Mr. Eckenweiler continued by saying, “The ability for our shareholders to directly connect Rêveur Corporation revenue to LDS is beneficial for the Company and its shareholders, we are looking forward to our fourth quarter revenue results. Rêveur Corporation has generated over two million dollars in revenue to date.” The Company will continue to update interested parties with respect to all operations of Rêveur Corporation. About Rêveur Corporation On behalf of the board of directors of Lifestyle Delivery Systems Inc. Brad Eckenweiler Suite 820, 1130 W. Pender St. CSE : LDS OTCQB : LDSYF Frankfurt: LD6, WKN: A14XHT www.lifestyledeliverysystem.com FOR MORE INFORMATION, PLEASE CONTACT: Cautionary Disclaimer Statement: Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.
07.11.2018 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |